Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Catalent Pharma Solutions | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Catalent Pharma Solutions

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

George L. Fotiades has been appointed interim president and chief executive officer of Catalent Pharma Solutions, effective immediately. John W. Lowry, the incumbent in this role, is leaving Catalent to pursue other opportunities. The search for Mr. Lowry’s replacement is ongoing.

Mr. Fotiades has served as chairman since Catalent’s creation in 2007 and will continue to serve in that capacity. He brings strong experience to this role, having led the business from 2000 through 2004. Mr. Lowry will  assist Mr. Fotiades during the leadership transition.

Mr Fotiades said, “I would like to recognize John Lowry’s important contributions to Catalent over the last seven years, and particularly the leadership continuity and focus he brought during our transition to a standalone company. I am also pleased to assume an even more active role during this transition to help drive Catalent’s future success.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters